Showing results (1351-1360 of 1,436) with videos related to

Sort By:
Pageof 144
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 8, 2025
Neoadjuvant radiochemotherapy in patients with high-risk locally advanced cervical cancer-results of a clinical seriesS Donath, M A Schirmer, F Bremmer, et al.
Nutrients|April 3, 2020
<i>Lactobacillus Acidophilus/Bifidobacterium Infantis</i> Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human MilkIngmar Fortmann, Janina Marißen, Bastian Siller, et al.
Cancer Research|December 28, 2013
A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignanciesDamian J Green, Nural N Orgun, Jon C Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantationRyan D Cassaday, Katherine A Guthrie, Elizabeth L Budde, et al.
British Journal of Haematology|October 13, 2015
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphomaRyan D Cassaday, Philip A Stevenson, Theodore A Gooley, et al.
The New England Journal of Medicine|December 8, 2015
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic LeukemiaAndrew W Roberts, Matthew S Davids, John M Pagel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignanciesEneida R Nemecek, Katherine A Guthrie, Mohamed L Sorror, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE StudyWilliam G Wierda, John N Allan, Tanya Siddiqi, et al.
Blood|February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment optionsMichael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.
Molecular Metabolism|April 13, 2016
Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitisTorsten Schröder, David Kucharczyk, Florian Bär, et al.
Pageof 144